Cannabis Sciences 2020

Kent Crowley, Pharm.D., is a board-certified Pharm.D. through the American Academy of Anti-Aging Medicine. He received his Doctor of Pharmacy from University of California, San Francisco and completed his residency with Kaiser Permanente in Los Angeles, CA. He completed his ... Fellowship in Metabolic and Nutritional Medicine in 2011. During his 34 years in practice, he has worked in primary research at UCI, Dept. of Pediatrics, Division of Child Development, involved in the development of several drugs; holds two patents in neuropathic pain and a patent on a buccal delivery system incorporating cannabis. Dr. Crowley currently is the Director of R&D at Silver State Trading in Sparks, NV, a 40,000 sq.ft. permitted Clean Green cannabis cultivation and production facility. He serves as the CMO for the Palliative Care Corporation in Huntington Beach, CA, working with patients & physicians incorporating cannabis in disease state treatment and symptoms management, whether as a primary treatment or complementary to traditional and/or other modalities. This same approach is practiced through Bud and Bloom in Santa Ana, CA as a clinic day each week for patients to come to a Best in Class dispensary and get good information/education on cannabis products/dosage forms/routes of administration and incorporate that into a functional medicine consult for personalized treatment goals. Dr. Crowley is a member of the Society of Cannabis Clinicians and serves on the Research Subcommittee and a member of the International Cannabinoid Research Society.

Russell Cersosimo Jr. is the founder of Pittsburgh-based Miradati Technology, which is currently developing HIPAA-compliant, enterprise software that creates standardized data for medical cannabis research. Integrating both legacy and proprietary technologies, Miradati helps ... facilitate this rapidly developing field of study, producing quantifiable data that more accurately measures patient outcomes, reduces prescribing errors and lowers patient costs. Up until 2104, it's safe to say Cersosimo had, at best, an agnostic view of the medicinal benefits of the popular recreational drug. That would soon change after he was introduced to the family of Hannah Shuker, an 11 year-old girl with severe intractable epilepsy. Hannah instantly captured Cersosimo's heart and the desire to help save her life forever changed his. Witnessing first hand how profoundly cannabis could improve Hannah's condition, Cersosimo made it his mission to help get such medicine into the hands of other patients and families, equally desperate for hope. These efforts led him in 2015 to found the Pennsylvania Medical Cannabis Society (PAMCS), the Commonwealth of Pennsylvania's largest organization for professionals, educators and leaders in the industry. It should come as no surprise that PAMCS' and Cersosimo's advocacy efforts were instrumental in 2016's successful legalization campaign. Today, Cersosimo is committed to forging partnerships that improve the capture and analysis of medical cannabis data. Cersosimo is passionate about developing solutions that will shape the industry and help more patients like Hannah around the world. With that operating vision at its core, Cersosimo's Keystone Integrated Care, was recently awarded multiple licenses to operate medicinal dispensaries throughout southwestern Pennsylvania. A serial entrepreneur as far back as his days studying Psychology at West Virginia University, Cersosimo founded Webbula, a data-centric technology company. As its CEO, Cersosimo generated high-profile clientele including Google, Yahoo, T-Mobile, Neustar, and Epsilon. Mr. Cersosimo has also served as CEO for marketing firm Optimal Reach Media. He currently sits on the Board of Directors of the Tourettes Syndrome Awareness Foundation.

James Eaves received his Ph.D. in Agricultural Economics from the University of California at Davis. He is currently a professor at Université Laval, where his research focuses on methods of improving the profitability of growing cannabis indoors at scale. He has worked with a ... number of large cannabis producers on various research projects, and he was the Head of R&D for Greenseal Cannabis Company.

Gia is currently working as an independent consultant supporting the agricultural biotechnology industry, after leaving in 2017 as the Director of Project Planning with Arcadia Biosciences managing the program portfolio of the company. Prior to that she managed the Analytical ... Science and Regulatory Support group for nearly 5 years, performing crop analysis and generating data for regulatory approvals through the FDA, USDA and multiple international agencies. Before that she worked as a principal scientist also at Arcadia in the Nitrogen Use Efficiency Program generating metabolic and protein fingerprints for engineered plant lines. She has also worked as a Research Technician at Rice University between undergrad and graduate school. Gia has a PhD in Biochemistry from Rice University (2007) and graduated from Indiana University (2001) with a BS in Biology, where she studied plant natural products and protein chemistry, respectively.

Justin Kander is the Patient Coordinator for The Oil Plant, a licensed manufacturer of whole-plant cannabis medicines in California. He has been with the company and its associated brand Aunt Zelda's since July 2015. In 2008, he began collecting research and experiences ... surrounding the use of cannabis to treat cancer, and eventually published several books on the subject. Justin has presented at medical cannabis conferences to further share information as widely as possible.

Debra Kimless, M.D. graduated magna cum laude, Phi Beta Kappa from Muhlenberg College with a double major in Natural Sciences and Biology. She attended medical school at Rutgers, and residency at Temple University Hospital and is a boarded Anesthesiologist with a subspecialty ... certification in Pain Medicine.

Catharine is a Scientific Operations, Principal Scientist at Waters Corporation based in Milford, MA. She began her career at a fast paced, biopharmaceutical R&D contract research laboratory where she was responsible for designing analytical methods used for characterization of ... novel biological therapeutics. Catharine spent many years working in large pharma, and later moved into instrument development. At Waters Corporation, she works closely with scientists, engineers, and technical experts throughout the world to innovate, develop, and advance analytical technologies.

Allegra Leghissa graduated with her PhD in analytical chemistry from the University of Texas at Arlington in July 2018, working under the direction of Prof. Kevin A. Schug. She was born and raised in Bologna, Italy. She left Italy in August 2014 after completing an undergraduate ... Chemistry degree at the University of Bologna.

Jahan Marcu, Ph.D., is currently the Chief Science Officer at Americans for Safe Access (a medical cannabis advocacy non-profit) and Director of the Patient Focused Certification program, which is a health and safety oversight program that assesses regulatory compliance at ... cannabis operations. He is co-founder and past-chairman of the CANN subdivision of the Chemical Health and Safety Division (DCHAS) of the American Chemical Society. His is also on the Board of Directors of the International Association for Cannabinoids as Medicine. He has a background in analytical chemistry and molecular pharmacology, he received his Ph.D. for contributions in characterizing the structure and function of the cannabinoid receptors. He is an author of the American Herbal Pharmacopeia's Cannabis Monograph and serves on multiple expert government, trade association committees, scientific organizations including AHPA, ACS, AOCS, AOAC, ASA, IACM, and IMCPC. And is a court-qualified synthetic cannabinoid and cannabis expert. He has helped create medical cannabis educational training for clinicians and for workers in the medical cannabis industry, and has been invited to speak at many international conferences and universities, including the University of Leiden, Temple University School of Medicine, Princeton Hospital, and Yale University. Dr. Marcu is also a court qualified expert witness on cannabis and synthetic cannabinoids.

Dr. Paszko is the Sr. Vice President at Accelerated Technology Laboratories, Inc. a LIMS, laboratory automation and informatics firm. She is an innovative, customer-centric leader with strong communication skills and the ability to collaborate well with both technical and sales ... teams. She received her undergraduate degree in Medical Technology (MT ASCP), with a minor in Microbiology from the State University of New York @ Buffalo. Her graduate studies were conducted at the University of Maryland in Molecular Microbiology with an emphasis in infectious diseases and informatics. Her unique career combines a Ph.D. with 20+ years of experience in working in laboratories and leveraging data management tools, LIMS and automation. These tools enhance data quality, facilitate regulatory compliance, increase productivity, and the ability better manage laboratory data and information. She has co-authored a book on LIMS, and authored over 5 dozen scientific, LIMS and informatics articles in peer reviewed journals. Dr. Paszko has been helping analytical testing laboratories understand regulatory compliance requirements (ISO 17025), leverage LIMS and automation to increase productivity, throughput and profitability. This approach has helped customers to outperform competitors with best in class Laboratory Information Management Systems Technology, Automation, Systems Integration to offer insights into laboratory and business intelligence.